The FDA has approved deuruxolitinib as a first-line treatment for adults with moderate to severe alopecia areata (AA). 1 Deuruxolitinib, developed by Sun Pharma, is an oral selective inhibitor of ...

KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced that the U.S. Food and Drug Administration (FDA) has approved EKTERLY® (sebetralstat), a novel ...

Matthew Riccardi was just 11 years old when he was diagnosed with the same condition: alopecia areata, an autoimmune disorder ...